Please login to the form below
cholera
This page shows the latest cholera news and features for those working in and with pharma, biotech and healthcare.
UK to launch world-first COVID-19 human challenge study in the ‘next few weeks’
Human challenge studies have been used previously to support the development of treatments for a range of disease, including malaria, typhoid, cholera, norovirus and influenza.
Latest news
-
UK COVID-19 vaccine ‘challenge trials’ could intentionally infect participants with virus
In the past, this type of trial has been used to investigate a range of diseases, including influenza, malaria, typhoid, dengue fever and cholera.
-
Givlaari, Rybelsus lead crowded CHMP recommendations
The CHMP also recommended PaxVax’s cholera vaccine Vaxchora for prophylaxis against choleam and Eli Lilly’s new fast-acting mealtime insulin Liumjev, to improve glycemic control in diabetes in adults.
-
The power of pharma businesses to drive social change
Our research teams are collaborating with peers from organisations around the world to help in the development of effective treatments for diseases such as Chagas, cholera, dengue fever and schistosomiasis.
-
FDA approves first cholera vaccine in US
The approval also comes against the backdrop of a worldwide shortage in oral cholera vaccines, which include Valneva's Dukoral and the International Vaccine Institute's Shanchol. ... It is a live attenuated vaccine, incorporating a weakened strain of the
-
Sanofi enters vaccines partnership with Sutro
Sanofi Pasteur's vaccines currently cover 20 infectious diseases, including tuberculosis, cholera, influenza and hepatitis, and it is currently investigating a product to protect against the dengue virus.
UK COVID-19 vaccine ‘challenge trials’ could intentionally infect participants with virus
Givlaari, Rybelsus lead crowded CHMP recommendations
The power of pharma businesses to drive social change
FDA approves first cholera vaccine in US
Sanofi enters vaccines partnership with Sutro
More from news
Approximately 1 fully matching, plus 11 partially matching documents found.
Latest from PMHub
-
Love in the Time of Coronavirus
Recommended reading: Love in the Time of Cholera by Gabriel Garcia Marquez, a story about how love can survive a lifetime of separation, including a cholera epidemic. ... The cholera epidemic of 1854 led the physician John Snow to conclude that the
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director, Medical & Brand Communications, Lon...
-
Highly competitive salary
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Account Director, Medical & Brand Communications, London/ SE...
-
Highly competitive salary
- Editorial Director - UK, , EUROPE, REMOTE.
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Management Trainer, Medical Communications, Londo...
-
Highly competitive salary
- Medical Writer, Women’s health, Medical Communications agency, h...
-
Highly competitive salary
- Freelance Scientific Director, Medical Communications, London/ S...
-
Highly competitive salary
- EU “still interested” in Valneva COVID vaccine despite UK snub
- US demand for COVID-19 antibody treatments rising fast
- One dose of AZ’s COVID-19 vaccine ‘highly effective’ against severe disease from variants
- AstraZeneca’s Imfinzi provides sustained survival benefit for lung cancer patients
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- Havas Life Medicom and ARK lead at 2021 PM Society Digital Awards
- Fishawack Health appoints Elizabeth Landon in the newly created Chief People Officer role
- Gilead’s Veklury (remdesivir) cuts risk of severe COVID-19 by 87%
- Amgen’s Biosimilar Trends Report shows benefit of competition from biosimilars
- Cuttsy+Cuttsy awarded Gold accreditation by Investors in People
- Nudging someone in the right direction isn’t always easy – that’s where behavioural science comes in
- OPEN Health Acquires ARK
No results were found
PMHub
Origins Insights
Our goal is to identify and embed transformational patient insights as a fundamental part of the drug development process. As...
Latest intelligence
- Robust Review: COVID19 Assessment
- See how our client utilized Rapid Payer Response (RPR) to stay informed and gain continuous insights during the recent global pandemic (COVID19)...
- All change – how untangling human behaviour can encourage better health
- Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
